An evaluation of the GPC's pilot project, which resulted in an EGD on the study of therapies for Alzheimer's disease.

As part of its exploration on the feasibility of developing clinical studies design guidance to meet the needs of Health Technology Assessment (HTA) organizations and coverage bodies, the GPC produced an Effective Guidance Document (EGD) that provides trial design recommendations for the study of pharmacological therapies for Alzheimer’s disease (AD).

The collaborative also produced this evaluation of the pilot project. This document explores the challenges and opportunities of international collaboration on such guidance.

Tags:

• Green Park Collaborative
• Meeting Summaries
• Alzheimer's

Download

• GPC Pilot Project Evaluation Report